Cargando…
Ex Vivo Chemosensitivity Profiling of Acute Myeloid Leukemia and Its Correlation With Clinical Response and Outcome to Chemotherapy
We evaluated the predictive value of the ex-vivo PharmaFlow PM platform in measuring the pharmacological activity of drug combinations consisting of 20 different chemotherapy regimens (20 Tx) administered in 104 acute myeloid leukemia (AML) patients. The predicted sensitivities of alternative treatm...
Autores principales: | Zhang, Yi, Ji, Min, Zhao, Jin-Yan, Wang, Hua-Feng, Wang, Chong-Wu, Li, Wei, Ye, Jing-Jing, Lu, Fei, Lin, Li-Hui, Gao, Yan-Ting, Jin, Jie, Li, Li, Ji, Chun-Yan, Ballesteros, Joan, Zhu, Hong-Hu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767104/ https://www.ncbi.nlm.nih.gov/pubmed/35071002 http://dx.doi.org/10.3389/fonc.2021.793773 |
Ejemplares similares
-
Differences in ex-vivo Chemosensitivity to Anthracyclines in First Line Acute Myeloid Leukemia
por: Megías-Vericat, Juan Eduardo, et al.
Publicado: (2019) -
Successful Anti-CLL1 CAR T-Cell Therapy in Secondary Acute Myeloid Leukemia
por: Zhang, Hui, et al.
Publicado: (2020) -
Immune cell proportions correlate with clinicogenomic features and ex vivo drug responses in acute myeloid leukemia
por: Romine, Kyle A., et al.
Publicado: (2023) -
Characteristics of Pyroptosis-Related Subtypes and Novel Scoring Tool for the Prognosis and Chemotherapy Response in Acute Myeloid Leukemia
por: Pan, Jingjing, et al.
Publicado: (2022) -
Research progress on molecular biomarkers of acute myeloid leukemia
por: Yin, Pei-Yuan, et al.
Publicado: (2023)